Evaluation and diagnostic testing of erectile dysfunction in the era of phosphodiesterase type 5 inhibitors

Authors

  • Kenneth Jacobsohn,

    1. Department of Urology, University of Texas Health Science Center and MD Anderson Cancer Center, Houston, Texas 77030, USA
    Search for more papers by this author
  • Run Wang

    Corresponding author
    1. Department of Urology, University of Texas Health Science Center and MD Anderson Cancer Center, Houston, Texas 77030, USA
      Run Wang, MD, FACS, Department of Urology, University of Texas Health Science Center and MD Anderson Cancer Center, Houston, Texas 77030, USA. Tel: +1-713-500-7337 Fax: +1-713-500-7319 E-mail: Run.Wang@uth.tmc.edu
    Search for more papers by this author

Run Wang, MD, FACS, Department of Urology, University of Texas Health Science Center and MD Anderson Cancer Center, Houston, Texas 77030, USA. Tel: +1-713-500-7337 Fax: +1-713-500-7319 E-mail: Run.Wang@uth.tmc.edu

Abstract

The diagnosis and treatment of erectile dysfunction has changed dramatically since the availability of safe and effective oral therapies. Unfortunately, not all men can be adequately treated in this way, and might require more invasive testing to diagnose and treat the specific cause of their dysfunction. This review looks at the tests and strategies available for men who cannot be treated by oral therapy alone.

Edited by Profs Steven M. Schrader and Guang-Huan Sun

Ancillary